BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 1 day ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 day ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 1 day ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 day ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
Market News

Biogen’s quarterly profit jumps but stock falls

American biotech firm Biogen (BIIB), whose shares fell nearly 16.5% this year, saw it further dip 2.4% to $259.30 in pre-market trade, despite the strong first-quarter…

Market News

Pfizer’s cancer drug hits FDA roadblock

With the loss of patent protection for its flagship drugs – Lipitor and Viagra – drugmaker Pfizer (PFE) has been struggling to revive its sales. The…

Market News

April 23: Top 52-week highs and lows of the day

Eleven Biotherapeutics Inc. (EBIO), a biologic oncology company, touched a new yearly high of $2.12 on Monday. According to a report, the results are expected…